OIS-XIV-Web

The Ophthalmology Innovation Summit

NOVEMBER 22-23 | SAN DIEGO, CA - HARD ROCK HOTEL

Connecting clinical, corporate, and capital leaders to drive the ophthalmic market forward. This two-day event will showcase groundbreaking advancements and clinical insights in both anterior and posterior ophthalmology segments and promises unmatched learning, networking, and collaboration.

OIS XIV ONSITE

The Ophthalmology Innovation Summit

NOVEMBER 22-23 | SAN DIEGO, CA - HARD ROCK HOTEL

ADVISORY BOARD

Sharon-2020

Sharon Bakalash, MD, PhD

Paul Bresge

Paul Bresge

Emmett 2024

Emmett T. Cunningham Jr., MD, PhD, MPH

Pravin U. Dugel, MD

Pravin U. Dugel, MD

Daniela (1)

Daniela Ferrara, MD, MS, PhD, FASRS

Firas M. Rahhal, MD

Firas Rahhal, MD

Rob Rothman 2023

Rob Rothman, MD

Anthony Wallace

Anthony Wallace

Fouteen-14
Susan Benton 2024

Susan Benton

President - i2eye Consulting LLC

The OIS meeting is one of the most relevant and best forums for bringing together all stakeholders involved in ophthalmic innovation. The program delivers quality content from a diverse group of experts across both the pharmaceutical and med device spaces. This is a must attend program for anyone who is developing tomorrow's innovation today.

Veysel Ozkapici Headshot

Veysel Ozkapici

CEO - GlaucoT

Participating in OIS XIV was an exceptional experience for GlaucoT. The conference provided a unique platform to showcase our innovative solutions for glaucoma management, including our groundbreaking wearable neuroprotective system and the novel mobile camera-based intraocular pressure measurement technology. Engaging with leading experts, investors, and strategic partners in the ophthalmology space was invaluable. The insightful discussions and feedback we received have further fueled our mission to revolutionize glaucoma treatment. We are grateful for the opportunity to connect with such a vibrant and forward-thinking community and look forward to continuing our journey with the momentum gained from OIS XIV.

David Killengray Headshot (1)

David Killengray

Chief Commercial Officer - Medevise Consulting

OIS represents a great opportunity to see the coming developments in ophthalmology, delivered by innovators. There is a real opportunity to learn about the issues affecting startups and the process of getting an idea realized into a product and beyond.

Sanjeev Ganatra Headshot

Sanjeev Ganatra

Global Head, Ophthalmology - CBCC Global Research

OIS continues to be true to its name as the Ophthalmic Innovation Source. A source for early companies to have a friendly and welcoming on ramp into eye care and a source for investors and strategic companies to be introduced to and evaluate the next generation of innovators and innovations.

JameMurrey-square

James Murray

Managing Partner - ExSight Ventures

OIS continues to be a must attend event for anyone in the ophthalmology space. The organizers curate an ever-evolving slate of discussions that reflect the market and set the tone for the next year.

Jeroen_Wissink2

Jeroen Wissink

CEO - Uneedle

This is networking to the max.